Novel Compounds as Glucagon Receptor Agonists for Treating Type 2 Diabetes Mellitus and Obesity

Provided herein are novel compounds as glucagon receptor agonists, pharmaceutical compositions, use of such compounds in treating type 2 diabetes mellitus and obesity, and processes for preparing such compounds.

Authors

Ram W. Sabnis (ORCID: https://orcid.org/0000-0001-7289-0581)

Publication Details

Journal: ACS Medicinal Chemistry Letters
Published: 2025-12-18
DOI: https://doi.org/10.1021/acsmedchemlett.5c00732
Citations: 2
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 2.59

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Novel Compounds as Glucagon Receptor Agonists for Treating Type 2 Diabetes Mellitus and Obesity

Ram W. Sabnis

Dec 18, 2025

2 citations

ACS Medicinal Chemistry Letters

Diabetes Treatment and Management

2.59

article

Novel Compounds as Glucagon Receptor Agonists for Treating Type 2 Diabetes Mellitus and Obesity

Ram W. Sabnis

December 18, 2025article en

2 citations

Abstract

ACS Medicinal Chemistry LettersVol. 17(1)

Openalex Percentile: Top 8%

Diabetes Treatment and Management

2.59

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Novel Compounds as Glucagon Receptor Agonists for Treating Type 2 Diabetes Mellitus and Obesity — Ram W. Sabnis · ACS Medicinal Chemistry Letters (2025) | TGRS Research Map | TGRS